JP2020033290A - 水性組成物 - Google Patents

水性組成物 Download PDF

Info

Publication number
JP2020033290A
JP2020033290A JP2018160272A JP2018160272A JP2020033290A JP 2020033290 A JP2020033290 A JP 2020033290A JP 2018160272 A JP2018160272 A JP 2018160272A JP 2018160272 A JP2018160272 A JP 2018160272A JP 2020033290 A JP2020033290 A JP 2020033290A
Authority
JP
Japan
Prior art keywords
group
salt
solvate
aqueous composition
brimonidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018160272A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020033290A5 (enExample
Inventor
宏彰 久我
Hiroaki Kuga
宏彰 久我
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Priority to JP2018160272A priority Critical patent/JP2020033290A/ja
Publication of JP2020033290A publication Critical patent/JP2020033290A/ja
Publication of JP2020033290A5 publication Critical patent/JP2020033290A5/ja
Priority to JP2023025162A priority patent/JP2023062143A/ja
Priority to JP2024165820A priority patent/JP2024169649A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018160272A 2018-08-29 2018-08-29 水性組成物 Pending JP2020033290A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2018160272A JP2020033290A (ja) 2018-08-29 2018-08-29 水性組成物
JP2023025162A JP2023062143A (ja) 2018-08-29 2023-02-21 水性組成物
JP2024165820A JP2024169649A (ja) 2018-08-29 2024-09-25 水性組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018160272A JP2020033290A (ja) 2018-08-29 2018-08-29 水性組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023025162A Division JP2023062143A (ja) 2018-08-29 2023-02-21 水性組成物

Publications (2)

Publication Number Publication Date
JP2020033290A true JP2020033290A (ja) 2020-03-05
JP2020033290A5 JP2020033290A5 (enExample) 2021-07-26

Family

ID=69667062

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018160272A Pending JP2020033290A (ja) 2018-08-29 2018-08-29 水性組成物
JP2023025162A Pending JP2023062143A (ja) 2018-08-29 2023-02-21 水性組成物
JP2024165820A Pending JP2024169649A (ja) 2018-08-29 2024-09-25 水性組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023025162A Pending JP2023062143A (ja) 2018-08-29 2023-02-21 水性組成物
JP2024165820A Pending JP2024169649A (ja) 2018-08-29 2024-09-25 水性組成物

Country Status (1)

Country Link
JP (3) JP2020033290A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022075472A1 (ja) * 2020-10-09 2022-04-14 アイ・セラピーズ・エル・エル・シー ブリモニジンの液体製剤
WO2022097731A1 (ja) * 2020-11-06 2022-05-12 アイ・セラピーズ・エル・エル・シー 眼科用液体製剤
US20230218627A1 (en) * 2020-05-06 2023-07-13 Pharmathen S.A. Preservative free pharmaceutical composition for ophthalmic administration comprising brimonidine

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316441B1 (en) * 1998-12-17 2001-11-13 Alcon Manufacturing, Ltd. Brinzolamide and brimonidine for treating glaucoma
WO2008024846A2 (en) * 2006-08-25 2008-02-28 Allergan, Inc. Brimonidine and timolol compositions
JP2014031369A (ja) * 2012-07-13 2014-02-20 Santen Pharmaceut Co Ltd スルホンアミド化合物の組み合わせ
WO2016093344A1 (ja) * 2014-12-12 2016-06-16 興和株式会社 新規水性組成物
JP2016529297A (ja) * 2013-08-28 2016-09-23 プレスバイオピア・セラピーズ・エル・エル・シー 老視を治療するための組成物及び方法
WO2017115238A1 (en) * 2015-12-29 2017-07-06 Roberto Pinelli Compositions for the treatment of presbyopia
JP2017149711A (ja) * 2016-02-22 2017-08-31 参天製薬株式会社 ドルゾラミドとブリモニジンを含む医薬組成物
JP2017525686A (ja) * 2014-07-28 2017-09-07 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ 薬物のバイオアベイラビリティーの増加および／または眼作用の持続方法
JP2017226652A (ja) * 2016-06-15 2017-12-28 興和株式会社 水性の組成物
JP2019104727A (ja) * 2017-12-08 2019-06-27 千寿製薬株式会社 水溶性高分子を含む水性液剤
JP2019182848A (ja) * 2018-03-30 2019-10-24 千寿製薬株式会社 水性液剤

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316441B1 (en) * 1998-12-17 2001-11-13 Alcon Manufacturing, Ltd. Brinzolamide and brimonidine for treating glaucoma
WO2008024846A2 (en) * 2006-08-25 2008-02-28 Allergan, Inc. Brimonidine and timolol compositions
JP2014031369A (ja) * 2012-07-13 2014-02-20 Santen Pharmaceut Co Ltd スルホンアミド化合物の組み合わせ
JP2016529297A (ja) * 2013-08-28 2016-09-23 プレスバイオピア・セラピーズ・エル・エル・シー 老視を治療するための組成物及び方法
JP2017525686A (ja) * 2014-07-28 2017-09-07 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ 薬物のバイオアベイラビリティーの増加および／または眼作用の持続方法
WO2016093344A1 (ja) * 2014-12-12 2016-06-16 興和株式会社 新規水性組成物
WO2017115238A1 (en) * 2015-12-29 2017-07-06 Roberto Pinelli Compositions for the treatment of presbyopia
JP2017149711A (ja) * 2016-02-22 2017-08-31 参天製薬株式会社 ドルゾラミドとブリモニジンを含む医薬組成物
JP2017226652A (ja) * 2016-06-15 2017-12-28 興和株式会社 水性の組成物
JP2019104727A (ja) * 2017-12-08 2019-06-27 千寿製薬株式会社 水溶性高分子を含む水性液剤
JP2019182848A (ja) * 2018-03-30 2019-10-24 千寿製薬株式会社 水性液剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
医薬品インタビューフォーム ラタノプロスト点眼液０．００５％「科研」, JPN6023044394, 2017, ISSN: 0005182047 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230218627A1 (en) * 2020-05-06 2023-07-13 Pharmathen S.A. Preservative free pharmaceutical composition for ophthalmic administration comprising brimonidine
WO2022075472A1 (ja) * 2020-10-09 2022-04-14 アイ・セラピーズ・エル・エル・シー ブリモニジンの液体製剤
JP2022063252A (ja) * 2020-10-09 2022-04-21 千寿製薬株式会社 ブリモニジンの液体製剤
WO2022097731A1 (ja) * 2020-11-06 2022-05-12 アイ・セラピーズ・エル・エル・シー 眼科用液体製剤
JP2022075651A (ja) * 2020-11-06 2022-05-18 千寿製薬株式会社 眼科用液体製剤

Also Published As

Publication number Publication date
JP2023062143A (ja) 2023-05-02
JP2024169649A (ja) 2024-12-05

Similar Documents

Publication Publication Date Title
JP7469427B2 (ja) 医薬製剤（２）
JP2024160370A (ja) 医薬品その６
JP2023062143A (ja) 水性組成物
US10220043B2 (en) Aqueous composition
JP2024020404A (ja) 水性の組成物－肆－
JP2023029543A (ja) 眼科用組成物 その３
EP3590515A1 (en) Medicine
WO2016093346A1 (ja) 水性組成物
JP6267839B1 (ja) 水性組成物
JP2017226651A (ja) 水性なる組成物
JP2016113458A (ja) 新水性組成物
JP7137677B2 (ja) 水性組成物（さん）
JP2017226650A (ja) 水性的組成物
WO2017217478A1 (ja) 眼科用組成物
JP2016113459A (ja) 水性である組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210526

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210526

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220301

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220419

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220617

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221025

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230221

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230829

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230906

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20231027